Tracking the Risk of Cardiovascular Disease after Almond and Oat Milk Intervene or Statin Medication with a Powerful

Chia-Hsuan Cheng1,2, Hiromi Yatsuda1,2, Han-Hsiang Chen3

  • 1Graduate School of Science and Technology, Shizuoka University, 3-5-1 Johoku, Naka-ku, Hamama-tsu-shi 432-8561, Japan.

PubMed

Insights

A new point-of-care test (POCT) for apolipoprotein B (ApoB) using a shear horizontal surface acoustic wave (SH-SAW) platform effectively monitors cardiovascular disease (CVD) risk. Both almond/oat milk and statin interventions significantly lowered ApoB levels.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Medicine
  • Point-of-Care Diagnostics

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Early detection and monitoring of lipid status are crucial for high-risk individuals.
  • Current hospital-based lipid measurements require large optical detection machines, necessitating point-of-care testing (POCT) for effective CVD monitoring.

Purpose of the Study:

  • To develop a novel POCT approach for apolipoprotein B (ApoB) detection.
  • To utilize a shear horizontal surface acoustic wave (SH-SAW) platform for assessing heart disease risk.
  • To evaluate the efficacy of interventions on ApoB levels using the developed POCT.

Main Methods:

  • Development of a reflective SH-SAW sensor to minimize device size and amplify signals.
  • Application of the SH-SAW platform for monitoring ApoB levels.
  • Assessment of changes in ApoB levels following a four-week intervention with almond/oat milk or statins.

Main Results:

  • The SH-SAW ApoB test demonstrated a linear range of 0-212 mg/dL with a high coefficient of correlation (R=0.9912).
  • Both almond/oat milk and statin interventions led to significant reductions in ApoB levels (-23.3% and -53.1%, respectively; p < 0.05 and p < 0.01).

Conclusions:

  • The SH-SAW POCT device shows promise as a valuable tool for monitoring CVD risk.
  • This technology can facilitate frequent monitoring during routine follow-up visits.
  • The study validates the impact of lifestyle and pharmacological interventions on ApoB levels.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
135
Atherosclerosis II: Clinical manifestations and prevention01:27

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
1
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
1
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
558
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
3
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
1